Furthermore, cholinergic signaling due to nAChR activation is also implicated in Alzheimer’s and Parkinson’s diseases [101], [102], schizophrenia [103], and depression [104], among other pathological conditions. Here, CHRNA4 is linked to major depressive disorder.